On Saturday the Department of War’s Office of Strategic Capital signed a conditional loan commitment of up to $80 million to Antheia, a Menlo Park biotech that makes pharmaceutical ingredients by fermentation instead of in chemical plants overseas. The stated reason is that the United States imports roughly 90% of the key starting materials...